Montpellier, October 12-13, 2012
«8ème Séminaire Européen d’Immuno-Rhumatologie»
Program draft
BeTheCure Workshop
”microRNA: a novel class of immuno-biologics in chronic inflammatory disorders”
October 12th, 2012
Opening: Christian Jorgensen welcome
12:00 – 13:00 Welcome-buffet, registration
Session clinical Immunology. Innovative immunotherapy in autoimmune diseases
Chairs:
Invited speaker:
13:00 – 13:30 Molecular therapies for systemic lupus erythematosus: clinical trials and future prospects. Sylviane Muller, (Strasbourg)
13:30 – 14:00 Therapeutic inhibition of proteasomes in systemic lupus erythematosus R Voll (Berlin)
Session 1: miRNAs and immune response
Chairs:
Invited speaker
14:20 – 14:50 Monsef Benkirane (France) ” miRNAs and viruses”
BTC groups
14:50 – 15:10 Mir-Farzin Mashrehi (Germany) ” MicroRNAs regulating the expansion and survival of proinflammatory T Helper cells”
15:10 – 15:30 Panagiotis Verginis (Greece) ” Role of miR-21 in aberrant T cell responses in human SLE”
15:30 – 15:50 Hans Yssel (Fance) ”miRNA in human Thelper cell subsets”
Invited speaker
15:50 – 16:30 M. Stoffel (Switzerland) ”miRNAs and metabolic disorders”
16:30 – 17:00 Coffee break
Session 2: miRNAs in rheumatic diseases
Chairs:
Invited speaker
17:00 – 17.30 Philippe Georgel (France) ” Involvement of the miRs 17-92 Cluster in inflammation”
BTC groups
17:30 – 17:50 Steffen Gay (Switzerland) ”miRNA in the pathogenic role of fibroblasts in RA and SSc”
17:50 – 18:10 Ioannis Pandis (Greece) "Discovery of novel human RA-SFmodulatingmiRNAs by profilingthe human TNF transgenic mouse miRnome"
18:10 – 18:30 Mariola Kurowska-Stolarska (UK) ”miR-155 as a proinflammatory regulator of arthritis”
18:30 – 18:50 Stephen Bluml (Vienna) ” Control of auto-immunity by micro RNAs”
19:30 – 22:00 Dinner
October 13th, 2012
Session 3: RNAi-based therapeutics: IP issues
Chairs:
Invited speaker
09:00 – 09:30 Asuragen (US) ” A success story bringing miRNA mimics into the clinic”
BTC groups
09:30 – 09:50 Inserm-Transfert (France)
09:50 – 10:10 ”miR as a quality signature of cell product” SYSTEMIC (Glasgow) Vincent O'Brien
10:10 – 10:30 miRNA/biomarker Alessandra Cervino (TCLand Nantes, France)
Invited speaker
10:30 – 11:00 Hervé Seitz (France) ” miRNA-guided repression vs. biological robustness: revisiting the significance of miRNA-mediated regulation”
11:00- 11:30 Valérie Geoffroy (Inserm) ”miR regulation of runx2 in osteogenesis”
11:00 – 11:30 Coffee break
11:30 – 13:30: Round table for BTC groups
13:30 – Lunch, departure
HOTEL MERCURE MONTPELLIER ANTIGONE
285 bd de l'Aéroport International-34000 MONTPELLIER
( 00 33 (0)4 67 20 63 63
Distances : de l'aéroport 4 km, de la gare SNCF 2 km (èTram Direction Odysseum - arrêt Place de l'Europe)
Parking : Europa (face à l'hôtel) ou Odysseum (èTram Direction Mosson - arrêt Place de l'Europe)
Localisation et Plan d'accès :
Par la A9 en provenance de Nîmes :èMontpellier/Perpignan
Sortie Montpellier EstèMillénaireèCentre Ville
Par la A9 en provenance de Perpignan:èMontpellier/Nîmes
Sortie Montpellier EstèMillénaireèCentre Ville
Remerciements
Le Comité d’Organisation de l’association ARTIMA tient à exprimer leurs remerciements aux Laboratoires SCHERING-PLOUGH/Pfizer, Wyeth, Roche, UCB dont le soutien important a permis la réalisation de ce septième séminaire européen dédié aux maladies auto-immunes